ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pneumococcal Polysaccharide Vaccine Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-38E17811
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Pneumococcal Polysaccharide Vaccine Market Research Report 2024
BUY CHAPTERS

Global Pneumococcal Polysaccharide Vaccine Market Research Report 2024

Code: QYRE-Auto-38E17811
Report
August 2024
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi Pasteur
Vendors
Merck
Pfizer Inc
Walvax
Sinovac
Sino Biopharm
Kangtai Bio
Zhifei Biological
AIM Bio
Antejin Biotechnology

Pneumococcal Polysaccharide Vaccine Market

The global Pneumococcal Polysaccharide Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Pneumococcal Polysaccharide Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pneumococcal Polysaccharide Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pneumococcal Polysaccharide Vaccine include Merck & Co., Pfizer, Sanofi Pasteur, Walvax, Sinovac, Sino Biopharm, Kangtai Bio, Zhifei Biological, AIM Bio, Antejin Biotechnology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pneumococcal Polysaccharide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumococcal Polysaccharide Vaccine.
The Pneumococcal Polysaccharide Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Pneumococcal Polysaccharide Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pneumococcal Polysaccharide Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pneumococcal Polysaccharide Vaccine Market Report

Report Metric Details
Report Name Pneumococcal Polysaccharide Vaccine Market
Segment by Type
  • PCV13
  • PPSV23
  • Others
Segment by Application
  • Hospital
  • Centers for Disease Control and Prevention
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck & Co., Pfizer, Sanofi Pasteur, Walvax, Sinovac, Sino Biopharm, Kangtai Bio, Zhifei Biological, AIM Bio, Antejin Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pneumococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pneumococcal Polysaccharide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Pneumococcal Polysaccharide Vaccine Market report?

Ans: The main players in the Pneumococcal Polysaccharide Vaccine Market are Merck & Co., Pfizer, Sanofi Pasteur, Walvax, Sinovac, Sino Biopharm, Kangtai Bio, Zhifei Biological, AIM Bio, Antejin Biotechnology

What are the Application segmentation covered in the Pneumococcal Polysaccharide Vaccine Market report?

Ans: The Applications covered in the Pneumococcal Polysaccharide Vaccine Market report are Hospital, Centers for Disease Control and Prevention, Others

What are the Type segmentation covered in the Pneumococcal Polysaccharide Vaccine Market report?

Ans: The Types covered in the Pneumococcal Polysaccharide Vaccine Market report are PCV13, PPSV23, Others

Recommended Reports

Pneumococcal & Meningococcal Vaccines

Broad-spectrum & Viral Vaccines

Vaccine Adjuvants & Packaging

1 Pneumococcal Polysaccharide Vaccine Market Overview
1.1 Product Definition
1.2 Pneumococcal Polysaccharide Vaccine by Type
1.2.1 Global Pneumococcal Polysaccharide Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 PCV13
1.2.3 PPSV23
1.2.4 Others
1.3 Pneumococcal Polysaccharide Vaccine by Application
1.3.1 Global Pneumococcal Polysaccharide Vaccine Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Centers for Disease Control and Prevention
1.3.4 Others
1.4 Global Pneumococcal Polysaccharide Vaccine Market Size Estimates and Forecasts
1.4.1 Global Pneumococcal Polysaccharide Vaccine Revenue 2019-2030
1.4.2 Global Pneumococcal Polysaccharide Vaccine Sales 2019-2030
1.4.3 Global Pneumococcal Polysaccharide Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pneumococcal Polysaccharide Vaccine Market Competition by Manufacturers
2.1 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pneumococcal Polysaccharide Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Pneumococcal Polysaccharide Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pneumococcal Polysaccharide Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pneumococcal Polysaccharide Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Pneumococcal Polysaccharide Vaccine, Date of Enter into This Industry
2.8 Global Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends
2.8.1 Global Pneumococcal Polysaccharide Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pneumococcal Polysaccharide Vaccine Players Market Share by Revenue
2.8.3 Global Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pneumococcal Polysaccharide Vaccine Market Scenario by Region
3.1 Global Pneumococcal Polysaccharide Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pneumococcal Polysaccharide Vaccine Sales by Region: 2019-2030
3.2.1 Global Pneumococcal Polysaccharide Vaccine Sales by Region: 2019-2024
3.2.2 Global Pneumococcal Polysaccharide Vaccine Sales by Region: 2025-2030
3.3 Global Pneumococcal Polysaccharide Vaccine Revenue by Region: 2019-2030
3.3.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Region: 2019-2024
3.3.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Region: 2025-2030
3.4 North America Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.4.1 North America Pneumococcal Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2030)
3.4.3 North America Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.5.1 Europe Pneumococcal Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2030)
3.5.3 Europe Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Pneumococcal Polysaccharide Vaccine Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Region (2019-2030)
3.6.3 Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.7.1 Latin America Pneumococcal Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Pneumococcal Polysaccharide Vaccine Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2030)
4.1.1 Global Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024)
4.1.2 Global Pneumococcal Polysaccharide Vaccine Sales by Type (2025-2030)
4.1.3 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2019-2030)
4.2.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2019-2024)
4.2.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2025-2030)
4.2.3 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Pneumococcal Polysaccharide Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2030)
5.1.1 Global Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024)
5.1.2 Global Pneumococcal Polysaccharide Vaccine Sales by Application (2025-2030)
5.1.3 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2019-2030)
5.2.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2019-2024)
5.2.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2025-2030)
5.2.3 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Pneumococcal Polysaccharide Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck & Co.
6.1.1 Merck & Co. Company Information
6.1.2 Merck & Co. Description and Business Overview
6.1.3 Merck & Co. Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck & Co. Pneumococcal Polysaccharide Vaccine Product Portfolio
6.1.5 Merck & Co. Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Pneumococcal Polysaccharide Vaccine Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Sanofi Pasteur
6.3.1 Sanofi Pasteur Company Information
6.3.2 Sanofi Pasteur Description and Business Overview
6.3.3 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Product Portfolio
6.3.5 Sanofi Pasteur Recent Developments/Updates
6.4 Walvax
6.4.1 Walvax Company Information
6.4.2 Walvax Description and Business Overview
6.4.3 Walvax Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Walvax Pneumococcal Polysaccharide Vaccine Product Portfolio
6.4.5 Walvax Recent Developments/Updates
6.5 Sinovac
6.5.1 Sinovac Company Information
6.5.2 Sinovac Description and Business Overview
6.5.3 Sinovac Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sinovac Pneumococcal Polysaccharide Vaccine Product Portfolio
6.5.5 Sinovac Recent Developments/Updates
6.6 Sino Biopharm
6.6.1 Sino Biopharm Company Information
6.6.2 Sino Biopharm Description and Business Overview
6.6.3 Sino Biopharm Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sino Biopharm Pneumococcal Polysaccharide Vaccine Product Portfolio
6.6.5 Sino Biopharm Recent Developments/Updates
6.7 Kangtai Bio
6.7.1 Kangtai Bio Company Information
6.7.2 Kangtai Bio Description and Business Overview
6.7.3 Kangtai Bio Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Kangtai Bio Pneumococcal Polysaccharide Vaccine Product Portfolio
6.7.5 Kangtai Bio Recent Developments/Updates
6.8 Zhifei Biological
6.8.1 Zhifei Biological Company Information
6.8.2 Zhifei Biological Description and Business Overview
6.8.3 Zhifei Biological Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Zhifei Biological Pneumococcal Polysaccharide Vaccine Product Portfolio
6.8.5 Zhifei Biological Recent Developments/Updates
6.9 AIM Bio
6.9.1 AIM Bio Company Information
6.9.2 AIM Bio Description and Business Overview
6.9.3 AIM Bio Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 AIM Bio Pneumococcal Polysaccharide Vaccine Product Portfolio
6.9.5 AIM Bio Recent Developments/Updates
6.10 Antejin Biotechnology
6.10.1 Antejin Biotechnology Company Information
6.10.2 Antejin Biotechnology Description and Business Overview
6.10.3 Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Product Portfolio
6.10.5 Antejin Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pneumococcal Polysaccharide Vaccine Industry Chain Analysis
7.2 Pneumococcal Polysaccharide Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pneumococcal Polysaccharide Vaccine Production Mode & Process
7.4 Pneumococcal Polysaccharide Vaccine Sales and Marketing
7.4.1 Pneumococcal Polysaccharide Vaccine Sales Channels
7.4.2 Pneumococcal Polysaccharide Vaccine Distributors
7.5 Pneumococcal Polysaccharide Vaccine Customers
8 Pneumococcal Polysaccharide Vaccine Market Dynamics
8.1 Pneumococcal Polysaccharide Vaccine Industry Trends
8.2 Pneumococcal Polysaccharide Vaccine Market Drivers
8.3 Pneumococcal Polysaccharide Vaccine Market Challenges
8.4 Pneumococcal Polysaccharide Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi Pasteur
Vendors
Merck
Pfizer Inc
Walvax
Sinovac
Sino Biopharm
Kangtai Bio
Zhifei Biological
AIM Bio
Antejin Biotechnology
List of Tables
 Table 1. Global Pneumococcal Polysaccharide Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Pneumococcal Polysaccharide Vaccine Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Pneumococcal Polysaccharide Vaccine Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Pneumococcal Polysaccharide Vaccine Sales (Dose) of Key Manufacturers (2019-2024)
 Table 5. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Pneumococcal Polysaccharide Vaccine Average Price (US$/Dose) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Pneumococcal Polysaccharide Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pneumococcal Polysaccharide Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pneumococcal Polysaccharide Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Pneumococcal Polysaccharide Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pneumococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Polysaccharide Vaccine as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pneumococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Pneumococcal Polysaccharide Vaccine Sales by Region (2019-2024) & (Dose)
 Table 18. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2019-2024)
 Table 19. Global Pneumococcal Polysaccharide Vaccine Sales by Region (2025-2030) & (Dose)
 Table 20. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2025-2030)
 Table 21. Global Pneumococcal Polysaccharide Vaccine Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2019-2024)
 Table 23. Global Pneumococcal Polysaccharide Vaccine Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2025-2030)
 Table 25. North America Pneumococcal Polysaccharide Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (Dose)
 Table 27. North America Pneumococcal Polysaccharide Vaccine Sales by Country (2025-2030) & (Dose)
 Table 28. North America Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Pneumococcal Polysaccharide Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Pneumococcal Polysaccharide Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (Dose)
 Table 32. Europe Pneumococcal Polysaccharide Vaccine Sales by Country (2025-2030) & (Dose)
 Table 33. Europe Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Pneumococcal Polysaccharide Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Region (2019-2024) & (Dose)
 Table 37. Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Region (2025-2030) & (Dose)
 Table 38. Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Pneumococcal Polysaccharide Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (Dose)
 Table 42. Latin America Pneumococcal Polysaccharide Vaccine Sales by Country (2025-2030) & (Dose)
 Table 43. Latin America Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (Dose)
 Table 47. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Country (2025-2030) & (Dose)
 Table 48. Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Pneumococcal Polysaccharide Vaccine Sales (Dose) by Type (2019-2024)
 Table 51. Global Pneumococcal Polysaccharide Vaccine Sales (Dose) by Type (2025-2030)
 Table 52. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
 Table 53. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2025-2030)
 Table 54. Global Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2019-2024)
 Table 57. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2025-2030)
 Table 58. Global Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Type (2019-2024)
 Table 59. Global Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Type (2025-2030)
 Table 60. Global Pneumococcal Polysaccharide Vaccine Sales (Dose) by Application (2019-2024)
 Table 61. Global Pneumococcal Polysaccharide Vaccine Sales (Dose) by Application (2025-2030)
 Table 62. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
 Table 63. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2025-2030)
 Table 64. Global Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2019-2024)
 Table 67. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2025-2030)
 Table 68. Global Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Application (2019-2024)
 Table 69. Global Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Application (2025-2030)
 Table 70. Merck & Co. Company Information
 Table 71. Merck & Co. Description and Business Overview
 Table 72. Merck & Co. Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 73. Merck & Co. Pneumococcal Polysaccharide Vaccine Product
 Table 74. Merck & Co. Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 78. Pfizer Pneumococcal Polysaccharide Vaccine Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Sanofi Pasteur Company Information
 Table 81. Sanofi Pasteur Description and Business Overview
 Table 82. Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 83. Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Product
 Table 84. Sanofi Pasteur Recent Developments/Updates
 Table 85. Walvax Company Information
 Table 86. Walvax Description and Business Overview
 Table 87. Walvax Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 88. Walvax Pneumococcal Polysaccharide Vaccine Product
 Table 89. Walvax Recent Developments/Updates
 Table 90. Sinovac Company Information
 Table 91. Sinovac Description and Business Overview
 Table 92. Sinovac Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 93. Sinovac Pneumococcal Polysaccharide Vaccine Product
 Table 94. Sinovac Recent Developments/Updates
 Table 95. Sino Biopharm Company Information
 Table 96. Sino Biopharm Description and Business Overview
 Table 97. Sino Biopharm Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 98. Sino Biopharm Pneumococcal Polysaccharide Vaccine Product
 Table 99. Sino Biopharm Recent Developments/Updates
 Table 100. Kangtai Bio Company Information
 Table 101. Kangtai Bio Description and Business Overview
 Table 102. Kangtai Bio Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 103. Kangtai Bio Pneumococcal Polysaccharide Vaccine Product
 Table 104. Kangtai Bio Recent Developments/Updates
 Table 105. Zhifei Biological Company Information
 Table 106. Zhifei Biological Description and Business Overview
 Table 107. Zhifei Biological Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 108. Zhifei Biological Pneumococcal Polysaccharide Vaccine Product
 Table 109. Zhifei Biological Recent Developments/Updates
 Table 110. AIM Bio Company Information
 Table 111. AIM Bio Description and Business Overview
 Table 112. AIM Bio Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 113. AIM Bio Pneumococcal Polysaccharide Vaccine Product
 Table 114. AIM Bio Recent Developments/Updates
 Table 115. Antejin Biotechnology Company Information
 Table 116. Antejin Biotechnology Description and Business Overview
 Table 117. Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 118. Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Product
 Table 119. Antejin Biotechnology Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Pneumococcal Polysaccharide Vaccine Distributors List
 Table 123. Pneumococcal Polysaccharide Vaccine Customers List
 Table 124. Pneumococcal Polysaccharide Vaccine Market Trends
 Table 125. Pneumococcal Polysaccharide Vaccine Market Drivers
 Table 126. Pneumococcal Polysaccharide Vaccine Market Challenges
 Table 127. Pneumococcal Polysaccharide Vaccine Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pneumococcal Polysaccharide Vaccine
 Figure 2. Global Pneumococcal Polysaccharide Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Pneumococcal Polysaccharide Vaccine Market Share by Type: 2023 & 2030
 Figure 4. PCV13 Product Picture
 Figure 5. PPSV23 Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Pneumococcal Polysaccharide Vaccine Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Pneumococcal Polysaccharide Vaccine Market Share by Application: 2023 & 2030
 Figure 9. Hospital
 Figure 10. Centers for Disease Control and Prevention
 Figure 11. Others
 Figure 12. Global Pneumococcal Polysaccharide Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Pneumococcal Polysaccharide Vaccine Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Pneumococcal Polysaccharide Vaccine Sales (2019-2030) & (Dose)
 Figure 15. Global Pneumococcal Polysaccharide Vaccine Average Price (US$/Dose) & (2019-2030)
 Figure 16. Pneumococcal Polysaccharide Vaccine Report Years Considered
 Figure 17. Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2023
 Figure 18. Global Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Pneumococcal Polysaccharide Vaccine Players: Market Share by Revenue in Pneumococcal Polysaccharide Vaccine in 2023
 Figure 20. Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Pneumococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2019-2030)
 Figure 23. North America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2019-2030)
 Figure 24. United States Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2019-2030)
 Figure 27. Europe Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2019-2030)
 Figure 35. China Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Pneumococcal Polysaccharide Vaccine by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Pneumococcal Polysaccharide Vaccine by Type (2019-2030)
 Figure 54. Global Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Pneumococcal Polysaccharide Vaccine by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Pneumococcal Polysaccharide Vaccine by Application (2019-2030)
 Figure 57. Global Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Application (2019-2030)
 Figure 58. Pneumococcal Polysaccharide Vaccine Value Chain
 Figure 59. Pneumococcal Polysaccharide Vaccine Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Research Report 2025
Global 13 Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Research Report 2024
Pneumococcal Vaccine Polyvalent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pneumococcal Testing Market Research Report 2024
Streptococcus Pneumoniae Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Group A and C Meningococcal Polysaccharide Vaccine Market Research Report 2024
Global 13 Valent Pneumococcal Conjugate Vaccine Market Research Report 2024
Multivalent Pneumococcal Conjugate Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pneumonia Vaccine Market Insights Forecast to 2030
Global Streptococcus Pneumoniae Antibodies Market Research Report 2024
23 valent Pneumococcal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
13 Valent Pneumococcal Polysaccharide Conjugate Vaccine PCV13 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Meningococcal Polysaccharide Vaccine Market Research Report 2025
Global Fungal Polysaccharide Market Research Report 2024
Global Pneumococcal Vaccination Market Research Report 2025
Pneumococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Pneumococcal Conjugate Vaccine PCV Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaccines for the Elderly Market Research Report 2024
Global Seasonal Vaccines Market Research Report 2024
Global Adult Vaccines Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions